- Home
- PBH
as 11-21-2024 2:38pm EST
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | TARRYTOWN |
| Market Cap: | 4.0B | IPO Year: | 2005 |
| Target Price: | $83.67 | AVG Volume (30 days): | 295.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 4.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $56.61 - $83.83 | Next Earning Date: | 11-07-2024 |
| Revenue: | $1,110,659,000 | Revenue Growth: | -1.45% |
| Revenue Growth (this year): | 1.57% | Revenue Growth (next year): | 2.54% |
Stock Insider Trading Activity of Prestige Consumer Healthcare Inc. (PBH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sacco Christine | PBH | Chief Financial Officer | Nov 12 '24 | Sell | $82.01 | 24,686 | $2,024,498.86 | 30,123 | |
| Mekhail Adel | PBH | EVP, Marketing & Sales | Nov 12 '24 | Sell | $82.00 | 9,063 | $743,166.00 | 18,365 |
Latest Prestige Consumer Healthcare Inc. News
PBH Breaking Stock News: Dive into PBH Ticker-Specific Updates for Smart Investing
Argus Research
9 days ago
PBH: Raising target price to $86.00
Zacks
10 days ago
All You Need to Know About Prestige Consumer Healthcare (PBH) Rating Upgrade to Buy
Simply Wall St.
11 days ago
Prestige Consumer Healthcare Inc. (NYSE:PBH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$85.29
GuruFocus.com
14 days ago
Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Highlights: Navigating Supply ...
Morningstar Research
14 days ago
Analyst Report: Prestige Consumer Healthcare Inc.
GlobeNewswire
14 days ago
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
Simply Wall St.
14 days ago
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 100% Above Its Share Price
Morningstar Research
15 days ago
Analyst Report: Prestige Consumer Healthcare Inc.
Compare PBH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PBH Prestige Consumer Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.